In a report released today, Difei Yang from Mizuho Securities reiterated a Buy rating on Avrobio (AVRO – Research Report),
Tag: Avrobio
Mizuho Securities Thinks Avrobio’s Stock is Going to Recover
In a report released today, Difei Yang from Mizuho Securities reiterated a Buy rating on Avrobio (AVRO – Research Report),
Mizuho Securities Thinks Avrobio’s Stock is Going to Recover
In a report released today, Difei Yang from Mizuho Securities reiterated a Buy rating on Avrobio (AVRO – Research Report),
Mizuho Securities Reaffirms Their Buy Rating on Avrobio (AVRO)
Mizuho Securities analyst Difei Yang reiterated a Buy rating on Avrobio (AVRO – Research Report) today and set a price
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avrobio (AVRO
Analysts Offer Insights on Healthcare Companies: Avrobio (NASDAQ: AVRO), Glaukos (NYSE: GKOS) and Global Blood Therapeutics (NASDAQ: GBT)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Avrobio (AVRO – Research Report),
Morgan Stanley Maintains Their Buy Rating on Avrobio (AVRO)
Morgan Stanley analyst David Lebovitz maintained a Buy rating on Avrobio (AVRO – Research Report) on October 12 and set